- MatsukiyoCocokara reported its 2Q operating income at 20.38 billion yen, a 1.4% increase year-over-year, but below the estimate of 20.6 billion yen.
- Net income for the quarter was 13.29 billion yen, a decline of 4% compared to the previous year, missing the estimate of 13.98 billion yen.
- Net sales reached 265.98 billion yen, which is a 2.5% increase year-over-year, but still below the estimated 268.3 billion yen.
- For 2025, the company maintains its forecast with operating income expected at 77.50 billion yen, slightly under the estimate of 78.86 billion yen.
- The net income forecast for 2025 stands at 52.50 billion yen, compared to the estimated 53.3 billion yen.
- Projected net sales are set at 1.05 trillion yen, slightly under the estimation of 1.06 trillion yen for the year 2025.
- The company expects a dividend of 42.00 yen, which is higher than the estimated 40.83 yen.
- The current stock recommendations show 11 buys, 5 holds, and 0 sells.
A look at MatsukiyoCocokara Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts using the Smartkarma Smart Scores system have provided an overall optimistic long-term outlook for MatsukiyoCocokara, a company that operates drug store chains. With a solid score of 4 in Growth and Resilience factors, it suggests that MatsukiyoCocokara is well-positioned for future expansion and is capable of weathering economic challenges. This indicates that the company has strong potential for growth and can adapt well to changing market conditions. Additionally, with respectable scores in Value and Dividend categories, MatsukiyoCocokara appears to offer a balanced blend of value and income to investors.
Although the Momentum score for MatsukiyoCocokara is rated at 3, slightly lower compared to Growth and Resilience, the overall outlook remains positive. The company’s diversified offerings in medicines, cosmetics, health foods, beauty care products, along with supermarkets and home centers, provide a stable foundation for potential growth. Investors may find MatsukiyoCocokara an attractive investment option based on the Smart Scores analysis, reflecting the company’s overall strength and potential for sustained performance in the long run.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
